Spironolactone Does Not Typically Cause Photosensitivity
Photosensitivity is not a recognized or commonly reported adverse effect of spironolactone based on current evidence. The FDA drug label does not list photosensitivity as an adverse reaction, and comprehensive dermatology guidelines discussing spironolactone's side effect profile do not mention it 1.
Evidence from Drug Labeling and Guidelines
The FDA-approved prescribing information for spironolactone provides an extensive list of adverse reactions, including:
- Skin reactions: Stevens-Johnson Syndrome, toxic epidermal necrolysis, drug rash with eosinophilia and systemic symptoms (DRESS), urticaria, maculopapular or erythematous eruptions, alopecia, and pruritus 1
- Common side effects: menstrual irregularities (15-30%), breast tenderness (3-5%), dizziness (3-4%), nausea (2-4%), headache (2%), polyuria (1-2%), and fatigue (1-2%) 2
Notably absent from this comprehensive list is any mention of photosensitivity or photoallergic reactions.
Clinical Experience and Long-Term Safety Data
The 2019 Journal of the American Academy of Dermatology guideline extensively reviews spironolactone's adverse effect profile for acne treatment, detailing multiple side effects but never mentioning photosensitivity 2.
Long-term safety studies support this finding. An 8-year follow-up study of 91 women taking spironolactone for acne (200 person-years of exposure) documented side effects in 59% of patients, with the most common being diuretic effects and menstrual irregularities—but no photosensitivity reactions were reported 3.
Important Caveat: Chloasma
There is one isolated case report from 1988 describing two patients who developed "chloasma" (melasma/hyperpigmentation) while on spironolactone 4. However, this is distinct from photosensitivity:
- Chloasma is a pigmentary disorder, not a photosensitive reaction
- This was described as a "previously unreported complication" in a small case series
- This has not been replicated in subsequent larger studies or included in drug labeling
Clinical Implications
When counseling patients starting spironolactone:
- Do not warn about photosensitivity as a standard precaution
- Focus on the documented common side effects: menstrual irregularities, breast tenderness, hyperkalemia risk (especially with ACE inhibitors or renal impairment), dizziness, and gastrointestinal symptoms 2, 1
- Monitor potassium within 1 week of initiation, especially in patients with renal impairment or those on interacting medications 1
- Counsel about pregnancy avoidance (Category C) 2
If a patient on spironolactone develops a photosensitive reaction, consider alternative drug causes or other dermatologic conditions rather than attributing it to spironolactone.